Literature DB >> 20921948

Dynamic control of the complement system by modulated expression of regulatory proteins.

Joshua M Thurman1, Brandon Renner.   

Abstract

The complement system serves many biological functions, including the eradication of invasive pathogens and the removal of damaged cells and immune-complexes. Uncontrolled complement activation causes injury to host cells, however, so adequate regulation of the system is essential. Control of the complement system is maintained by a group of cell surface and circulating proteins referred to as complement regulatory proteins. The expression of the cell surface complement regulatory proteins varies from tissue to tissue. Furthermore, specific cell types can upregulate or downregulate the expression of these proteins in response to a variety of signals or insults. Altered regulation of the complement regulatory proteins can have important effects on local complement activation. In some circumstances this can be beneficial, such as in the setting of certain infections. In other circumstances, however, this can be a cause of complement-mediated injury of the tissue. A full understanding of the mechanisms by which the complement system is modulated at the local level can have important implications for how we diagnose and treat a wide range of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921948      PMCID: PMC3109904          DOI: 10.1038/labinvest.2010.173

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  75 in total

1.  Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid.

Authors:  N Donin; K Jurianz; L Ziporen; S Schultz; M Kirschfink; Z Fishelson
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

2.  Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis.

Authors:  Russell W Read; Alexander J Szalai; Susan D Vogt; Gerald McGwin; Scott R Barnum
Journal:  Exp Eye Res       Date:  2005-09-06       Impact factor: 3.467

Review 3.  Decay-accelerating factor (CD55): a versatile acting molecule in human malignancies.

Authors:  Jan-Henrik Mikesch; Horst Buerger; Ronald Simon; Burkhard Brandt
Journal:  Biochim Biophys Acta       Date:  2006-05-09

4.  Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

5.  Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues.

Authors:  M Endoh; M Yamashina; H Ohi; K Funahashi; T Ikuno; T Yasugi; J P Atkinson; H Okada
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

6.  Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.

Authors:  B Li; C Sallee; M Dehoff; S Foley; H Molina; V M Holers
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

7.  Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells.

Authors:  F G Cosio; T Shibata; B H Rovin; D J Birmingham
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612

8.  Localization of the complement regulatory proteins in the normal human kidney.

Authors:  S Ichida; Y Yuzawa; H Okada; K Yoshioka; S Matsuo
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

9.  Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis.

Authors:  Cecile Canova; Jim W Neal; Philippe Gasque
Journal:  J Neuroinflammation       Date:  2006-09-02       Impact factor: 8.322

10.  Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis.

Authors:  Richard James Mead; James William Neal; Mark Raymond Griffiths; Christopher Linington; Marina Botto; Hans Lassmann; Bryan Paul Morgan
Journal:  Lab Invest       Date:  2004-01       Impact factor: 5.662

View more
  11 in total

1.  Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Authors:  L Cheng; S-J Gou; H-Y Qiu; L Ma; P Fu
Journal:  Clin Exp Immunol       Date:  2017-10-20       Impact factor: 4.330

2.  Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.

Authors:  Derek Leaderer; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  J Gene Med       Date:  2015 Jun-Jul       Impact factor: 4.565

Review 3.  The role of the complement system in acute kidney injury.

Authors:  James W McCullough; Brandon Renner; Joshua M Thurman
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

4.  Endothelial pentraxin 3 contributes to murine ischemic acute kidney injury.

Authors:  Jianlin Chen; Martin M Matzuk; Xin J Zhou; Christopher Y Lu
Journal:  Kidney Int       Date:  2012-08-15       Impact factor: 10.612

Review 5.  HUS and atypical HUS.

Authors:  T Sakari Jokiranta
Journal:  Blood       Date:  2017-04-17       Impact factor: 25.476

Review 6.  On the Functional Overlap between Complement and Anti-Microbial Peptides.

Authors:  Jana Zimmer; James Hobkirk; Fatima Mohamed; Michael J Browning; Cordula M Stover
Journal:  Front Immunol       Date:  2015-01-19       Impact factor: 7.561

7.  A Rare Case of Atypical Hemolytic Uremia Syndrome Triggered by Influenza Vaccination.

Authors:  Sanjay Kumar; Geeta Bhagia; Jessica Kaae
Journal:  Cureus       Date:  2022-03-28

Review 8.  Rheumatoid factor, complement, and mixed cryoglobulinemia.

Authors:  Peter D Gorevic
Journal:  Clin Dev Immunol       Date:  2012-08-26

9.  Complement Attack against Aspergillus and Corresponding Evasion Mechanisms.

Authors:  Cornelia Speth; Günter Rambach
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-08-09

10.  Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.

Authors:  Maaweya E Hamed; Asif Naeem; Haitham Alkadi; Aref A Alamri; Ahmad S AlYami; Abdullah AlJuryyan; Wael Alturaiki; Mushira Enani; Samia T Al-Shouli; Abdullah M Assiri; Bandar Alosaimi
Journal:  J Clin Immunol       Date:  2021-07-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.